Answers are grounded in this paper and cite their sources.
Since peritonitis remains a serious clinical problem, we have evaluated the prophylactic efficacy of intraperitoneally administered chemotactic substances in murine intraperitoneal infections. The injection of 10 ml of 3% thioglycollate increased the peritoneal white blood cell count of rats from 1.3 +/- 0.1 X 10(6) (mean +/- SEM) to 1.1 +/- 0.1 X 10(7) (mean +/- SEM) cells/ml. This increase in the number of intraperitoneal phagocytes resulted in reduction in mortality caused by an inoculum consisting of E. coli and hemoglobin from 68% in the control group to 29% in the thioglycollate pretreated group (p less than or equal to 0.02). Intraperitoneal injection of N-formyl-methionyl-phenylalanine (FMP), a chemotactically active oligopeptide, increased the intraperitoneal granulocyte count from virtually 0 to 1 X 1.9 +/- 0.53 X 10(4) (mean +/- SEM) cells/ml after 90 minutes. The rats pretreated in such a manner showed a mortality of 51% after an intraperitoneal challenge with an E. coli/hemoglobin inoculum as compared to a mortality of 72% in control animals (p less than or equal to 0.025). Thus, chemotactic substances can effectively increase the number of phagocytes and concurrently induce resistance to an intraperitoneal bacterial challenge.
No takes yet. Share an insight, caveat, or question.
Hau et al. (1980) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: